Guido Neels joins Endologix board of directors
This article was originally published in Clinica
Executive Summary
Irvine, California-based aortic treatment firm Endologix has added Guido Neels to its board of directors. Mr Neels is currently managing director at Essex Woodlands Health Ventures, a majority shareholder of Nellix – an endograft specialist acquired by Endologix earlier this year (www.clinica.co.uk, 28 October 2010). Mr Neels also holds board positions at oxygen saturation firm ROX Medical, endoscopic sinus surgery company Entellus Medical, stereotactic specialist Oraya Therapeutics, biomaterials expert Arsenal Medical and cryopreservation business EndGenitor Technologies. He was previously chief operating officer of Guidant, which was bought by Boston Scientific in 2006. The Endologix board now consists of five independent directors and three non-independent directors.